Advertisement

Topics

Europe Breast Cancer Screening Market Mammography, MRI Ultrasound Forecast to 2022 [Report Updated: 13062017] Prices from USD $1200

05:33 EDT 1 Jul 2017 | BioPortfolio Report Blog

Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe.


Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future

Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs. Under the programs, all women age between 5069 years are eligible for free breast cancer screening test in every two years. Under this program eligible woman gets a letter from the regional mammography program center to participate in the breast cancer screening program.


Germany will maintain their Dominating Position in Europe Breast Cancer Ultrasound Screening Market

Due to strong healthcare expending power and increasing breast cancer awareness among the women, Germany is forecast to hold its dominating place in Europe Breast Cancer Screening Market. Presently, Germany, Italy and Spain are steadily losing their market share on comparison to this all other countries such as United Kingdom, France, Switzerland, Norway and Netherlands ultrasound screening market share is expected to grow in the forecasting period 20172022.

Europe Breast Cancer Screening Mammography, MRI Ultrasound Market Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 8 countries: United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland

This 122 page report with 120 Figures and 2 Tables provides a complete analysis of top 8 courtiers of Europe Breast Cancer Screening Market. All the 8 countries in the report have been studied from 7 viewpoints.

Countries Breast Cancer Mammography Screening Population Scenario and Forecast
Countries Breast Cancer MRI Ultrasound Screening Population Scenario and Forecast
Countries Breast Cancer Mammography Screening Market and Forecast
Countries Breast Cancer MRI Screening Market and Forecast
Countries Breast Cancer Ultrasound Screening Market and Forecast
Countries Breast Cancer Screening Market and Forecast
Worldwide Breast Cancer Screening Market and Forecast


All the 8 Countries Studied in the Report are as Follows


1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Netherlands
7. Norway
8. Switzerland

Original Article: Europe Breast Cancer Screening Market Mammography, MRI Ultrasound Forecast to 2022 [Report Updated: 13062017] Prices from USD $1200

NEXT ARTICLE

More From BioPortfolio on "Europe Breast Cancer Screening Market Mammography, MRI Ultrasound Forecast to 2022 [Report Updated: 13062017] Prices from USD $1200"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...